Abstract
BackgroundThe paucity of tumor-specific targets for chimeric antigen receptor (CAR) T-cell therapy of solid tumors necessitates careful preclinical evaluation of the therapeutic window for candidate antigens. Human epidermal growth factor...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have